Source: PLOS ONE. Unidades: FM, FMRP
Subjects: INFARTO DO MIOCÁRDIO, FIBRINA, CÉLULAS USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKAMUTA, Juliana S. et al. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLOS ONE, v. 4, n. 6, p. e6005, 2009Tradução . . Disponível em: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005. Acesso em: 13 maio 2024.APA
Nakamuta, J. S., Danoviz, M. E., Marques, F. L. N., Santos, L. dos, Becker, C., Gonçalves, G. A., et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLOS ONE, 4( 6), e6005. Recuperado de http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005NLM
Nakamuta JS, Danoviz ME, Marques FLN, Santos L dos, Becker C, Gonçalves GA, Vassallo PF, Schettert IT, Tucci PJF, Krieger JE. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold [Internet]. PLOS ONE. 2009 ; 4( 6): e6005.[citado 2024 maio 13 ] Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005Vancouver
Nakamuta JS, Danoviz ME, Marques FLN, Santos L dos, Becker C, Gonçalves GA, Vassallo PF, Schettert IT, Tucci PJF, Krieger JE. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold [Internet]. PLOS ONE. 2009 ; 4( 6): e6005.[citado 2024 maio 13 ] Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005
